Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline <i>BRCA</i>-associated breast cancer (SWOG S1416).Priyanka Sharma, Gabriel N. Hortobágyi, William E. Barlow et al.|Journal of Clinical Oncology|2020Cited by 49